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Abstract:   
The opium poppy, Papaver somniferum, has been a source of medicinal alkaloids since the 
earliest civilizations; ca. 3400 B.C. The benzylisoquinoline alkaloid noscapine is produced 
commercially in P. somniferum for use as a cough suppressant and it also has potential as an 
anticancer compound. The first committed step in the recently elucidated noscapine 
biosynthetic pathway involves the conversion of scoulerine to tetrahydrocolumbamine by 9-
O-methylation, catalysed by O-methyltransferase 1 (PSMT1). We demonstrate, through 
protein structures (obtained through rational crystal engineering at resolutions from 1.5 to 
1.2Å for the engineered variants) across the reaction coordinate, how domain closure allows 
specific methyl transfer to generate the product. SAM-dependent methyl transfer is central 
to myriad natural products in plants, analysis of amino-acid sequence, now taking the three-
dimensional structure of PSMT1 and low identity homologs into account, begins to shed light 
on the structural features that govern substrate specificity in these key, ubiquitous, plant 
enzymes.  We propose how  “ŐĂƚĞŬĞĞƉĞƌ ?ƌĞƐŝĚƵĞƐĐĂŶĚĞƚĞƌŵŝŶĞĂĐĐĞƉƚŽƌƌĞŐŝŽĐŚĞŵŝƐƚƌǇ
thus allowing prediction across the wide genomic resource.  
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Introduction 
The medicinal properties of Papaver somniferum have been known and exploited since the 
first civilizations1-2. Noscapine is a major alkaloid that is found, along with the more commonly 
known drugs morphine and codeine, in the latex of opium poppy (Papaver somniferum). 
Noscapine has classically been utilised as a cough suppressant3, but recent research has been 
focused on its antitumor properties4-6. Unlike the better-known opiates, noscapine has no 
addictive properties7. The recent engineering of noscapine and a number of halogenated 
derivatives in Saccharomyces cerevisiae 8 opens up a new route to development of noscapine 
and its analogues as potential drug leads.  
A 10-gene cluster encoding all but one of the enzymes responsible for the conversion of 
scoulerine to noscapine was discovered and characterised by virus induced gene silencing and 
heterologous gene expression and this together with other studies has led to the proposition 
of the full biosynthetic pathway presented in Figure S19-12. The enzyme PSMT1, is the first 
enzymatic reaction catalysed by this gene cluster. The enzyme catalyses the 9-O-methylation 
of scoulerine by the S-adenosylmethionine (SAM) dependent Papaver somniferum O-
methyltransferase 1 (PSMT1)9, 13, Figure 1a.  
PSMT1 belongs to a group of ubiquitous enzymes termed methyltransferases that catalyse S-
adenosylmethionine dependent methyl transfer. Of particular interest, notably in plant 
methyltransferases, is the way in which diverse acceptors bind and are activated for catalysis.  
The first, seminal, insight into the structural basis for pant natural product modification was 
provided in 20-01 through the structure determination of two plant methyltransferases, 
Chalcone O-methyltransferase (PDB ID: 1FPQ, 1FP1) and Isoflavone O-methyltransferase (PDB 
ID: 1FPX, 1FP2) from Medicago sativa14.The Noel group were able to show that these enzymes 
possess SAM binding domains, as observed for diverse methyltransferases, across the tree of 
ůŝĨĞ ?ĂŶĚƐŚŽǁŚŽǁĂƐĞĐŽŶĚ “ĚŝŵĞƌŝǌĂƚŝŽŶ ?ĚŽŵĂŝŶĐŽŶƚƌŝďƵƚĞĚďŽƚŚƚŽƚŚĞĚŝŵĞƌĨŽƌŵĂƚŝŽŶ
and the acceptor substrate binding site.   
Extensive subsequent research undertaken on diverse SAM-dependent methyltransferases 
has highlighted five conserved motifs involved in SAM recognition15 including in diverse plant 
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methyltransferases, for example: Norcoclaurine 6-O-methyltransferase (PDB ID: 5ICC, 5ICE)16, 
and Caffeic acid O-methyltransferase (PDB ID: 3P9C, 3P9I, 3P9K)17. In contrast to SAM binding, 
detailed analysis of the methyl acceptor has been hindered by the large structural diversity of 
known substrates and to some extent the lack of high-resolution three-dimensional 
structures with the methyl acceptor bound. This is of considerable importance when one 
considers the large diversity in sequence-space and the rapidly increasing genomic resource.   
Acceptor binding and specificity are of additional interest in plant O-methyltransferases as 
these are a large family involved in biosynthetic pathways that lead to an array of biologically 
and medically-important compounds including lignols, flavonoids, phenylpropanoids, 
terpenoids and alkaloids. At the mechanistic level, it is clear that O-methylation is generally 
performed on a hydroxyl group on a phenolic or catecholic ring, and it has been proposed to 
proceed via SN2 type nucleophilic attack, with acceptor activation for catalysis via a general 
base mechanism featuring an Asp/His catalytic dyad. A consensus kinetic mechanism for this 
class of enzymes has yet to emerge, should it indeed exist, as it has been proposed to be both 
a random order and an ordered mechanism18-20. The development of next generation 
sequencing technologies and transcriptomic approaches have identified hundreds of 
predicted O-methyltransferases, with only a small number of these being biochemically 
characterised and an even smaller number having associated structural data14, 16-17, 19-23. This 
ůĂĐŬŽĨƐƚƌƵĐƚƵƌĂůŝŶƐŝŐŚƚŝŶƚŽƚŚĞƐƚƌƵĐƚƵƌĂů “ƐƉĂĐĞ ?ĨƵƌƚŚĞƌŚŝŶĚĞƌƐŐĞŶŽŵĞĂŶŶŽƚĂƚŝŽŶĂŶĚ
functional prediction.  
In this context, here we report on the three-dimensional structure and kinetic analysis of the 
Papaver somniferum O-methyltransferase PSMT1; which catalyses the 9-O-methylation of 
scoulerine, Figure 1.  PSMT1 displays less than 45% sequence identity to any OMT of known 
3-D structure, rendering modelling of its acceptor binding challenging.  Following a surface-
entropy reduction approach, crystals, diffracting beyond 1.3 Å, were obtained. We show how 
PSMT1 forms, as other plant OMTs, a multi-domain dimer, with domain opening and closing 
(16 degrees to yield 99.6% closure) reflecting the ligand-binding. High resolution studies thus 
provide an intimate analysis of both SAH and scoulerine binding.  The 3-D structure of PSMT1, 
when viewed in light of previous analyses now allows us to propose genomic analysis into the 
specificity and signature features of the wider plant methyltransferase superfamily, including 
  4 
ƚŚĞƉƌŽƉŽƐĂůŽĨ  “ŐĂƚĞŬĞĞƉĞƌ ?ƌĞƐŝĚƵĞƉŽƐŝƚŝŽŶƐƚŚĂƚĚĞƚĞƌŵŝŶĞƚŚĞ ŶĂƚƵƌĞ ŽĨƚŚĞĂĐĐĞƉƚŽƌ
substrate and its substituents.  
 
Results 
Expression, purification and catalytic activity of PSMT1 
The PSMT1 cDNA was expressed in Escherichia coli with an N-terminus hexa-histidine-
glutathione S-transferase (GST) purification/solubility tag and featuring a human rhinovirus 
3C protease (HRV-3CP) cleavage site in the linker. PSMT1 was purified utilising a multi-step 
purification procedure involving nickel affinity on-column cleavage by HRV-3C Protease, 
followed by desalting and anion exchange. The resulting protein was visualised by SDS-PAGE 
analysis with a single band of ca. 43 kDa visible. Size-exclusion multi-angle laser light 
scattering experiments (not shown) showed that PSMT1 is a homodimer in solution with a 
molecular weight of 83 kDa; consistent with other structurally-characterised plant O-
methyltransferases16-17, 19-23.  
In order to define the kinetics of the PSMT1 catalysed reaction, steady-state parameters were 
determined by quantitation of tetrahydrocolumbamine production using UPLC-MS/MS. Non-
linear regression analysis using the Michaelis-Menten equation produced a Vmax of 580 ±  45 
nmol min-1 mg-1 of protein with a Km ĨŽƌƐĐŽƵůĞƌŝŶĞŽĨ ? ? ? ?A? ? ? ? ?ʅD. While there appears to 
be ƐƵďƐƚƌĂƚĞŝŶŚŝďŝƚŝŽŶ ?ĂƉƉĂƌĞŶƚ<ŝ ? ?ʅD ?ĂƚŚŝŐŚƐĐŽƵůĞƌŝŶĞĐŽŶĐĞŶƚƌĂƚŝŽŶƐ, the error values 
are too large to demonstrate this unambiguously,  Figure 1b. When scoulerine was held at a 
ĨŝǆĞĚĐŽŶĐĞŶƚƌĂƚŝŽŶŽĨ ?ʅD ?ĂsŵĂǆŽĨ ? ? ?A? ? ?nmol min-1 mg-1 with a Km for SAM of 8.8 ± 
 ? ? ?ʅDǁĂƐĚĞƌŝǀĞĚ, Figure 1c. The kinetic values obtained for a near identical PSMT1 on the 
basis of an assay that relied on incorporation into tetrahydrocolumbamine of a radioactive 
methyl group from [methyl-14C]S-adenosylmethionine were Vmax of 2000 nmol min-1 mg-1 
and a Km for SAM of 19PM and a Km for scoulerine of 29PM 13. These are much higher than 
in the current study, particularly for the Km values. In the current study 
tetrahydrocolumbamine formation was measured directly by UPLC-MS/MS and it is possibly 
the different assay conditions that have caused this difference in kinetic values. Published Km 
values for other plant O-methyltransferases ŚĂǀĞďĞĞŶƌĞƉŽƌƚĞĚƚŽǀĂƌǇĨƌŽŵƚŚĞʅDƚŽŵD
range, although the weak binders in these studies are believed not to be the natural substrate 
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of these enzymes17, 24-27. Kinetics of surface and active-centre variants are described below in 
light of the three-dimensional structure of PSMT1.   
 
Figure 1. Reaction catalysed by PSMT1. (a) schematic of the PSMT1 catalysed reaction. 
Michaelis-Menten kinetics for O-methyltransferase (b) as a function of scoulerine 
concentration (c) as a function of SAM concentration. SAM: S-adenosylmethionine, SAH: S-
adenosylhomocysteine. Error bars represent the standard deviation of triplicate repeats.  
 
Overall structure of PSMT1 
Having established through kinetics analyses that the heterologously-expressed PSMT1 is 
functional, we next sought to determine the three-dimensional structure of the protein, in 
order to shed light on specificity and catalytic mechanism. Screening of purified PSMT1 
ƌĞǀĞĂůĞĚĂŶ ŝŶŝƚŝĂůĐƌǇƐƚĂů ĨŽƌŵĂůůŽǁŝŶŐĂĐĐĞƐƐƚŽĂŶ  ‘ĂƉŽ ?-PSMT1 structure, crystallised in 
space-group P3221, which diffracted to 3.05 Å, Figure 2a, Table S1. PSMT1 forms a 
symmetrical homodimer with an N-terminal dimerization domain and a SAM/SAH C-terminal 
Rossmann-ůŝŬĞĨŽůĚĚŽŵĂŝŶ ?ƐĞƉĂƌĂƚĞĚďǇĂƉƵƚĂƚŝǀĞɲ-helical substrate binding layer involved 
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with the dimerization. Co-crystallisation with SAM resulted in a, similarly weakly-diffracting, 
3 Å resolution structure with SAH and/or SAM bound at varied occupancy in an extended 
conformation on the C-terminal Rossmann-like fold domain. Both of these structures are 
ĐŽŶƐŝĚĞƌĞĚ “ŽƉĞŶ ? ?i.e., not in a conformation viable for methylation of the substrate. Domain 
motion has been demonstrated for an array of plant OMTs including caffeic acid O-
methyltransferase, isoflavone O-methyltransferase and norcoclaurine 6-O-
methyltransferase14, 16-17, where it is essential to bring the methyltransfer apparatus into close 
proximity to the acceptor hydroxyl. More discussion of ligand binding and conformational 
change will be given below, based upon much higher-resolution complexes.  
 
Surface entropy reduction allows dissection of donor and acceptor binding and 
conformational change in PSMT1 
Whilst medium-resolution analyses allowed a general description of topology, and to some 
extent donor binding, it was clear that detailed analysis of ligand-binding demanded a better-
diffracting crystal form that was also amenable to acceptor substrate binding. After 
exhaustive, unsuccessful screening, access to a closed conformation of PSMT1 was achieved 
using a rational surface engineering approach, based upon surface entropy reduction (SER), 
viewed in light of our low-resolution analysis.  SER was implemented utilising the UCLA MBI 
SER prediction (SERp) server28; primers in Table S2. Three clusters for mutagenesis were 
ƉƌŽƉŽƐĞĚĂŶĚŵĂƉƉĞĚŽŶƚŽƚŚĞůŽǁƌĞƐŽůƵƚŝŽŶ ‘ĂƉŽ ?ƐƚƌƵĐƚƵƌĞ ?Two of the clusters, residues 
114-115 and 128-129, were located on a flexible loop not defined in the electron density, 
suggesting they would make appropriate regions to reduce surface entropy and were 
therefore generated along with a double cluster mutant. The third cluster, residues 174-176, 
was located close to the dimer interface and was rejected due to the possibility of disturbing 
dimerization. 
A SER variant, PSMT1-SER, with Lys114 and Lys115 converted to alanine, allowed the growth 
of crystals in a new crystal form, when co-crystallised with SAH and scoulerine, in space group 
P21, with diffraction extending to 1.49 Å, Table S1. Michaelis-Menten kinetic analysis of 
PSMT1-SER confirmed that the two introduced residue changes had negligible effect on 
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enzyme activity parameters (Vmax, 450 nmol min-1 mg-1 of protein and Km,  ? ? ?ʅD, compared 
to Vmax, 580 ±  45 nmol min-1 mg-1 , Km for scoulerine,   ? ? ? ?A? ? ? ? ?ʅfor the wild type protein).   
Subsequent optimisation of co-crystallisation experiments with the substrates SAM and 
scoulerine, resulted in a 1.29 Å resolution product-bound structure with SAH and 
tetrahydrocolumbamine found in the catalytic centre. Binding of the ligands resulted in a 
large conformational change in which the SAM/SAH binding domains had rotated inwards in 
relation to the dimerization ĚŽŵĂŝŶƐŐĞŶĞƌĂƚŝŶŐ ƚŚĞ  “ĐůŽƐĞĚ-ĨŽƌŵ ? Figure 2b, causing the 
movement of the residues required to furnish competent active sites. 
 
Figure 2. Three-dimensional structure and ligand binding of PsMT1. W^Dd ? ‘ŽƉĞŶ ? ? ?ĂŶĚ
 ‘ĐůŽƐĞĚ ? ? ?ƐƚƌƵĐƚƵƌĞƐƌĞƉƌĞƐĞŶƚĞĚĂƐƌŝďďŽŶĚŝĂŐƌĂŵƐǁŝƚŚƚƌĂŶƐƉĂƌĞŶƚƐƵƌĨĂĐĞƐ ?In each case 
one monomer of the dimer is colour-ramped from N-terminus (blue) to C-terminus (red) 
whilst the other monomer is coloured by domain. SAH and tetrahydrocolumbamine bound in 
the active site, are shown as black cylinders. C and D show the interactions of SAH and 
tetrahydrocolumbamine, respectively in the SER variant structure co-crystallised with SAM 
and SCU (observed electron density is shown in Figure 3, below).  Domain opening/closing 
analysis was performed with DYNDOM29 from the CCP4 suite (domain movement available as 
a Web-Enhanced Object)  
 
SAM/SAH binding 
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The structure of PSMT1 co-crystallised with SAM in the open conformation features 
hydrolysed SAM, and is modelled with 2 molecules of SAH (associated with chains A and B) 
and 1 molecule of SAM (with the methyl group modelled at half occupancy, and C, O and OXT 
atoms at 0.3, in chain D), and has insufficient density to allow ligand to be fitted in chain C.  
The nucleotide adenine group of the (hydrolysed) donor molecules  interacts with the non-
polar side chains of Leu259, Met279, Phe280 and Trp298 and features hydrogen bonds 
betweenN1 and N Met279, and N6 and OD1 Asp278 in all 3 ligands, and also N3 and OD1 
Asp258 for SAM. Upon closure of the active site the interactions with SAM/SAH are 
maintained but with additional interactions made between Phe190, Phe203, Met207 and 
Ser211 from the alpha-helical layer, Figure 2C. The former three residues form a channel 
along with Trp293 and Asp297 into which the transferred methyl group extends allowing 
insight into catalytic mechanism, described, below.  There is very little movement of the 
residues lining the donor binding site upon binding of SAM (or SAH) in the "open" protein 
conformation, apart from rotation of the side chain of Asp258 by approximately 90 degrees 
to allow both OD atoms to form a hydrogen bond with a ribose hydroxyl group (OD1 to O2', 
OD2 to O3'). 
Consistent with generic features of plant SAM-dependent O-methyltransferase, Figure S2a, 
the ribose ring is also clamped in by a non-polar glycine rich segment Gly235-Gly236-Gly237. 
This glycine rich segment also forms one wall to the carboxypropyl moiety of methionine of 
the donor with Trp293 on the opposing side. The amine group of the methionine occupying 
the donor site  hydrogen bonds with the backbone oxygen of Lys292 for all 3 SAH/SAM 
molecules, and also the backbone oxygen of Gly235 for SAH in chain B. The side chain of 
Lys292 extends around to the carboxylic acid group of the methionine moiety making a 
ŚǇĚƌŽŐĞŶďŽŶĚǀŝĂ ŝƚƐƚĞƌŵŝŶĂů  ?Eɺ ?ĂŵŝŶŽŐƌŽƵƉ ?dŚĞŵĞƚŚǇůŐƌŽƵƉŽĨƚŚĞƐƵůƉŚŽŶŝƵŵŝŽŶ  
(for SAM) is positioned by Trp293 and Asp297 which direct it into the open cleft between the 
SAM binding domain and that of the putative substrate binding pocket. 
 
Acceptor substrate binding  
One of the motivations for this work is that residues involved in the recognition of the methyl 
acceptor substrate have been far less well characterised than those involved in SAM binding. 
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PSMT1 SER (WT or variant) structures with SAH and scoulerine or tetrahydrocolumbamine 
bound in the active site show essentially no difference in how the compounds are bound. 
Scoulerine and tetrahydrocolumbamine sit in a deep hydrophobic pocket fully occluded 
within the enzyme braced by hydrogen bonds between the hydroxyl groups at opposing ends 
of the compounds with Asp297 and Glu153, Figure 2d. The hydrophobic pocket is made up of 
residues Glu153, Phe,156, Thr157, Phe190, Phe203, Met207, Phe210, Trp293, Phe325, 
Asn339, Ile342, Pro343, Leu346, Leu347, Leu350 mainly from alpha helices seven from the 
dimerization domain, eleven, twelve and seventeen from the alpha-helical layer, and Thr39 
from alpha helix one of the opposing chain, Figure 2d.  
The A-ring of scoulerine is sandwiched, Figure 2d, ďĞƚǁĞĞŶWŚĞ ? ? ?ďǇĂɸ,-ʋŚǇĚƌŽŐen bond 
ĂŶĚŽŶƚŚĞŽƉƉŽƐŝŶŐĨĂĐĞŝŶƚĞƌĂĐƚƐǁŝƚŚ/ůĞ ? ? ?ĂŶĚWƌŽ ? ? ? ?dŚƌ ? ? ?ɶŵĂŬĞƐĂŚǇĚƌŽƉŚŽďŝĐ
ŝŶƚĞƌĂĐƚŝŽŶǁŝƚŚ ?ĂŶĚĂsĂŶĚĞƌtĂĂůƐ ?ŝŶƚĞƌĂĐƚŝŽŶǁŝƚŚ ?-OH of the A ring and it also makes 
a hydrogen bond with C3-O of scoulerine via a water molecule. The carboxylic acid group 
Glu153 hydrogen bonds directly to the 2-OH of scoulerine and to C3-O via a water molecule. 
The O3 of scoulerine hydrogen bonds to the backbone carbonyl of Thr39 of the opposing 
dimer chain via the same water molecule as Glu153. The 3-O-methyl group makes 
ŚǇĚƌŽƉŚŽďŝĐŝŶƚĞƌĂĐƚŝŽŶƐǁŝƚŚdŚƌ ? ?ĨƌŽŵƚŚĞŽƉƉŽƐŝŶŐĐŚĂŝŶĂŶĚƐŶ ? ? ?ɲ ?/ƚĂůƐŽŵĂŬĞƐ
sĂŶĚĞƌtĂĂůƐ ?ŝŶƚĞƌĂĐƚŝŽŶƐǁŝƚŚƚŚĞďĂĐŬďŽŶĞĐĂƌďŽŶǇůŐƌŽƵƉŽĨƐŶ ? ? ?ĂůŽŶŐǁŝƚŚŝƚƐɶ-
OH group. 
The B-ring of scoulerine makes hydrophobic interactions with Trp293, Pro343, Phe325 and 
His296. His296 also forms Van der WaĂůƐ ? ŝŶƚĞƌĂĐƚŝŽŶƐǁŝƚŚƐĐŽƵůĞƌŝŶĞE ?ǀŝĂŝƚƐɸ, ?dŚĞ-
ƌŝŶŐŵĂŬĞƐŚǇĚƌŽƉŚŽďŝĐŝŶƚĞƌĂĐƚŝŽŶƐǁŝƚŚdƌƉ ? ? ?ɴ ?,ŝƐ ? ? ?ɸĂŶĚ>ĞƵ ? ? ?ɷ ?dŚĞƌĞŝƐĂůƐŽ
a Van der Walls interaction beƚǁĞĞŶ,ŝƐ ? ? ?EɸĂŶĚ ?ĂŽĨƐĐŽƵůĞƌŝŶĞ ?dŚĞ-ring is held in 
ƉŽƐŝƚŝŽŶ ďǇ >ĞƵ ? ? ? ɷ,-ʋ ďŽŶĚŝŶŐ ĂŶĚ ŚǇĚƌŽƉŚŽďŝĐ ŝŶƚĞƌĂĐƚŝŽŶƐ ǁŝƚŚ >ĞƵ ? ? ? ? ĂůŽŶŐ ǁŝƚŚ
Phe156, Phe203 and Met207 interacting on the opposing face. The 10-methoxy position of 
scoulerine lies in a hydrophobic sheath formed byPhe190, Phe203 and Leu350, along with the 
carboxylic acid group of Asp297 via a hydrogen bond to its ether group. The 9-hydroxyl 
position of scoulerine is the hydroxyl group which is methylated by PSMT1. As expected this 
is highly co-ordinated making hydrogen bonds with the catalytic dyad of His296 and Asp279, 
as well as the backbone carbonyl of Trp293. Further analysis of acceptor binding, in light of 
the diversity of plant methyltransferase will be discussed below.  
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Ternary complex unveils the reaction mechanism of PsMT1 
Co-crystallisation with its substrates, resulted in enzymatic turnover and the products 
resulting in SAH and tetrahydrocolumbamine (Figure 1) observed at high resolution, Figure 
3a and hence the catalytic reaction mechanism may be inferred. Consistent with similar 
enzymes 16-17, 21 His296 likely acts as a general catalytic base deprotonating the 9-hydroxyl 
position of scoulerine during nucleophilic attack at the sulphonium methyl group of SAM, 
resulting in the 9-methyoxy product tetrahydrocolumbamine and SAH, Figure 3b. Glu356 acts 
ĂƐĂŚǇĚƌŽŐĞŶďŽŶĚĂĐĐĞƉƚŽƌĨŽƌ,ŝƐ ? ? ?Eɷ ?ƉƌŽŵŽƚŝŶŐthe required basicity and side-chain 
conformation.  
 
Figure 3.  Ligand binding and proposed reaction mechanism of PSMT1. (a) three-dimensional 
structure of the SAH and tetrahydrocolumbamine binding. The electron density map is a 
maximum-likelihood / VA weighted 2Fo-Fc synthesis, contoured at 0.44 electrons / Å3.  (b) 
Schematic diagram of reaction mechanism (c) Bar graph showing the activity of WT PSMT1 
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alongside the surface entropy reduction and two active site mutants. Reactions were carried 
out under representative Vmax ĐŽŶĚŝƚŝŽŶƐŽĨ ?ʅDƐĐŽƵůĞƌŝŶĞĂŶĚ ? ? ?ʅD^D ? 
 
In order to probe the catalytic mechanism, the two residues proposed to be important for the 
methyl transfer event, His296 and Asp297 were mutated to alanine. Mutations were 
introduced into the PSMT1 SER variant and the enzymes assayed under the same reaction 
conditions as previously but with ƐĐŽƵůĞƌŝŶĞĂŶĚ^DĂƚƐĂƚƵƌĂƚŝŶŐĐŽŶĐĞŶƚƌĂƚŝŽŶƐ ? ?ʅDĂŶĚ
 ? ? ?ʅD ?ƌĞƐƉĞĐƚŝǀĞůǇ ?dŚĞƌĞǁĂƐŶŽƐŝŐŶŝĨŝĐĂŶƚĚŝĨĨĞƌĞŶĐĞďĞƚǁĞĞŶƚŚĞƌĂƚĞŽĨW^Dd ?tdĂŶĚ
PSMT1 SER, whereas PSMT1 SER Asp297Ala possesses approximately 2 % activity compared 
to PSMT1 SER. PSMT1 SER His296Ala was inactive (although the protein was produced at 
lower levels, likely indicating reduced stability), Figure 3c. We conclude that Asp297 is 
important but not essential for catalysis, whereas His296 is critical for activity, consistent with 
its likely role in the initial deprotonation of the 9-hydroxyl group on scoulerine. In order to 
probe substrate binding further, X-ray structures of PSMT1 SER Asp297Ala were generated 
with SAM and scoulerine, resulting in observation of SAH and scoulerine bound in the active 
site. Intriguingly, although the Asp297Ala variant has allowed removal of the methyl group 
from SAM, no evidence of its transfer to scoulerine is observed in-crystal (not shown), which 
may indicate that the donor has been hydrolysed as observed in the WT structure, or that 
there was SAH contamination in the commercial SAM preparations.  
 
Three-dimensional structure reveals components of acceptor specificity in PSMT1 and 
beyond 
O-methyltransferases are a diverse group of enzymes which have evolved to accept a wide 
range of substrates including alkaloids and flavonoids. The substrate specificity of these type 
of enzymes is difficult to deduce based on primary sequence alone, due to their varying 
evolutionary paths. We set out to investigate how the PSMT1 could shed light on the 
mechanism and specificity of plant natural product O-methyltransferases, which display such 
diverse acceptor specificities.   
By harnessing a surface entropy approach our X-ray crystallographic structures have shown 
how the methyl donor SAM, as well as the acceptor/product 
scoulerine/tetrahydrocolumbamine are accommodated, which allows interrogation of the 
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sequence data in light of these structural facets.  Consistent with other reports (vide infra) we 
can conclude that generation of OMTs with altered substrate specificity appears to occur by 
gene duplication and neofunctionalization, with subsequent divergence of the acceptor 
binding pocket; the residues involved in the recognition of the phenolic ring of the substrate 
to be O-methylated are highly conserved, Figure S2b.  As proposed in classic work by the Noel 
group, Phe and Met side-chains above the phenolic ring and a Met side-chain below the ring 
appear to act as traps for the phenolic ring, with the conserved catalytic dyad of His and Asp 
providing the catalytic apparatus for methyl transfer14, 16-17, 19-22, 26, 30. In contrast, to this 
conserved methionine clamp, the residues responsible for the recognition of the variable 
chemical groups of the substrates are highly variable, but in light of the PSMT1 structure, and 
the increasing genomic and structural resource, we sought to analyse if any features were 
predictive of likely ligand shape and structure.  
A phylogenetic tree, using the characterized plant OMT sequences was constructed (see 
Methods) revealing an early evolutionary split into two groups of OMTs ( Figure S3). Analysis 
of the phylogenetic tree, through the telescope of molecular shape and connectivity and the 
known three-dimensional structures hints at some general recognition features. With a single 
exception, it was striking to us that one half of this evolutionary tree (sequences coloured 
black on Figure S3, Figure S4), has a small side chain (Gly, Ala, Ser, Thr, Cys, Val) at the position 
equivalent to Phe156 of PsMT1  W ƚŚĞ ƌĞƐŝĚƵĞ ƚŚĂƚ ƐŝƚƐ  “ŽƉƉŽƐŝƚĞ ? ƚŚĞ ƉŚĞŶŽůŝĐ ƌŝŶŐ ƚŽďĞ
methylated. Notably, 16 of these 19 sequences act on substrates with bulky substituents 
ŽƉƉŽƐŝƚĞ ?ƚŽƐŽŵĞĞǆƚĞŶƚ “para ? ?to the hydroxyl-group to be methylated strongly suggesting 
that this evolutionary group makes space for bulky ligands by simple steric means, reflected 
both in their evolutionary origin and fine sequence.  A small evolutionary clade, consisting 
three characterized enzymes (red) bucks this trend by acting on acceptors with bulky groups 
para to the hydroxyl but also possessing large groups predicted to occupy the position 
equivalent to Phe156. These enzymes, that act on reticuline and different xanthohumols, 
Figure S3, S4 have bulky groups opposite the hydroxyl (Phe, Met, Trp); unfortunately, no 
structural data exists for these enzymes, highlighting the need for further structural 
campaigns directly informed by these analyses.  
The second major evolutionary group (coloured blue in Figure S3, S4) which includes PSMT1 
primarily, but not exclusively have large amino acids in positions one would predict to lie 
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opposite the hydroxyl group to be methylated and to a large extent indeed work on substrates 
that have no steric bulk in such positions.   How the exceptions function, at a structural level 
is as yet unknown, but inspection of the three-dimensional structures, where known, 
confirms that bulky groups ŵĂǇ ĂĐƚ ĂƐ  “ŐĂƚĞŬĞĞƉĞƌƐ ? ĨŽƌ ƐƵďƐƚƌĂƚĞ ƌĞĐŽŐŶŝƚŝŽŶ; large 
hydrophobic groups act as gatekeeper residues, notably at positions equivalent to Phe156 
and to some extent Leu350 of PSMT1, for acceptor binding.  Where known structurally, large 
groups in these positions sterically hinder any group opposite to the target hydroxyl group, 
Figure 4a; a similar situation is observed in the Medicago sativa chalcone O-
methyltransferase (PDB code 1FP1) with Phe138 and Thr33214 playing similar roles, Figure 4b.  
 
Figure 4. Residues contributing to ligand shape recognition in characterized plant O-
methyltransferases. Phylogenetic analysis of characterized enzymes (Figure S4) and their 
sequence alignments (Figure S4). The catalytic His/Asp dyad are coloured magenta (as in 
Figure 3). Four examples are shown (a-d) with the ligand above and the three-dimensional 
structure of the ligand binding below (a) SAH-SCU Papaver somniferum O-methyltransferase 
1, this work (b)  ChOMT Medicago sativa Chalcone O-methyltransferase (PDB 1FP1; the ligand 
is in two position; the model with the correct E stereochemistry displays the best density and 
is shown) (c) IOMT Medicago sativa isoflavone O-methyltransferase (PDB 1FP2) (d) Thalictrum 
flavum norcoclaurine 6-O- methyltransferase (PDB 5ICE)) 
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In contrast, accommodation of substrates which extend in the opposition position  “ƉĂƌĂ͟ to 
the reactive hydroxyl group  is predominantly  reflected in enzymes that display smaller size 
chains at the position equivalent to Phe156, such as Cys and Thr in Medicago sativa isoflavone 
7-OMT (PDB code 1FP2) and Thalictrum flavum norcoclaurine 6-OMT (PDB code 5ICE)14, 16, 
Figure 4c,d.  This is also true in many other functionally characterised isoflavone OMTs and 
norcoclaurine OMTs (as reflected in the sequence alignment shown in Figure S5).  Hence, 
sequence divergences open up the active site, to allow ligands of different shape and 
structure; buried in the primary sequence is the basis for plant natural product modification 
that three-dimensional structure is beginning to illuminate as increasing numbers of three-
dimensional structures, coupled to enzyme characterization begin to emerge.  
Plant O-methyltransferases are a fascinating group of enzymes, which display exquisite 
divergence in their acceptor sites to allow methyl group transfer to a wide variety of alkaloids, 
flavonoids, lignols, phenylpropanoids, terpenoids and other diverse natural products. 
Understanding how the, necessarily exquisite, acceptor specificity is achieved will be central 
to both enzyme and system-wide engineering campaigns to understand, modify and exploit 
plant secondary metabolism. As noscapine-derived and inspired compounds become 
increasingly important as therapeutic agents (for recent examples see Refs 31-32) and in light 
of breakthroughs in the biosynthesis of noscapine in heterologous hosts systems8, we believe 
the dissection of PSMT1 reported here is an important step towards the goal of being able to 
predict substrate specificity of the growing number of methyltransferase genes in the public 
domain that will ultimately contribute to their exploitation in rational engineering of natural 
products.  
 
 
Methods 
Gene cloning and expression and protein purification 
 PSMT1 was recombinantly expressed as a His/GST-fusion protein (His-GST-r3CP-PSMT1), 
involving the use of the York Bioscience Technology Facility.  His-GST-r3CP-PSMT1 was grown in 500 
mL of Terrific-Broth (6 g tryptone, 12 g yeast extract, 2 mL glycerol, 17 mM KH2PO4, 72 mM K2HPO4) 
ĐŽŶƚĂŝŶŝŶŐ ? ? ?ʅŐŵ>-1 of kanamycin. Gene expression was induced by IPTG with a final concentration 
of 1 mM and cultivated at 16 ࣙC for 18 hours. Cells were harvested by centrifugation at 5,000 rpm at 
4 ࣙC for 30 minutes and resuspended in binding buffer comprised of 100 mM Tris pH 8.0, 500 mM 
EĂů ? ? ?ŵDŝŵŝĚĂǌŽůĞ ? ? ?ŵDɴ-mercaptoethanol, in a ratio of 1 g of cell pellet to 8 mL of binding 
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ďƵĨĨĞƌ ?ƉƌŽƚĞĂƐĞŝŶŚŝďŝƚŽƌĐŽĐŬƚĂŝůƚĂďůĞƚ ?ĐKŵƉůĞƚĞ ? ?ZŽĐŚĞ ?ĂŶĚ100 uL DNaseI at 2 mg mL-1 in 50% 
glycerol were added before lysis by sonication. The lysate was clarified by centrifugation at 18,000 
rpm for 45 minutes at 4 ࣙC and the supernatant filtered using a syringe through a 0.22 ʅm filter unit, 
before loading onto a 5 mL HisTrap FF Crude column (GE Healthcare). After washing the column with 
10 CVs of binding buffer, 5 mL 0.25 mg mL-1 HRV-3C protease were manually injected onto the column 
which was incubated overnight at 4 ࣙC. The HRV-3C protease  cleaved 6xHis-GST-r3CP-PSMT1 at the 
3CP recognition site (r3CP) giving rise to the purification/solubility tag (6xHis-GST), which remained 
bound to the column, and PSMT1 with a 3 residue N-terminus overhang. The liberated PSMT1 was 
washed off the column using binding buffer, and the bound proteins were eluted with binding buffer 
containing 0.5 M imidazole. Fractions containing PSMT1 were pooled and buffer exchanged into 
buffer A (100 mM TƌŝƐƉ, ? ? ? ? ? ?ŵDɴ-mercaptoethanol) using a HiPrep 26/60 Desalting column (GE 
Healthcare), before loading onto a 4.7 mL HiScreen Q HP anion exchange column (GE Healthcare), 
washed with 10 % buffer B (100 mM TƌŝƐƉ, ? ? ? ? ?DEĂů ? ? ?ŵDɴ-mercaptoethanol) and eluting 
with a gradient of 10-50 % buffer B. Fractions containing PSMT1 were pooled, buffer exchanged into 
10 mM TRIS pH 8.0, 5 mM TCEP and concentrated to 15 mg mL-1 using a 30 KDa cut-off centrifugal 
concentrator. All PSMT1 variants and their mutants were produced and purified in the same manner 
as PSMT1 WT. Purification steps were monitored by SDS-PAGE using 12 % gels and protein 
concentrations were determined by measuring absorbance at 280 nm and calculating from their 
predicted extinction coefficients. 
Site-directed mutagenesis experiments were carried out by PCR based whole plasmid amplification 
using oligonucleotides containing the target mutation, SI 8, followed by DpnI digestion of template 
DNA. Chemically competent E. coli XL10 gold cells were transformed with the products to allow 
plasmid amplification, and mutations were confirmed by DNA Sanger sequencing (GATC). 
 
PSMT1 Enzymatic Assays 
Standard enzyme activity assays were performed in 100 mM Gly-NaOH pH 9.0, 25 mM sodium 
ĂƐĐŽƌďĂƚĞ ? ?ŵDɴ-mercaptoethanol, 100 ʅD^ DĂŶĚ ? ʅDƐĐŽƵůĞƌŝŶĞĂƚ ? ? ࣙC. Assays were initiated 
ǁŝƚŚ ƚŚĞ ĂĚĚŝƚŝŽŶ ŽĨ  ? ? ? ŵ> ŽĨ  ? ʅŐ ŵ>-1 recombinant PSMT1 protein. Protein concentration was 
determined using absorbance at 280 nm and corrected based on quantification using the Bio-Rad 
Protein Assay Kit II, which is based on the Bradford assay. 1 mL aliquots were taken over 2.5 minutes 
and quenched with an equal volume of methanol. O-methylation of scoulerine to 
tetrahydrocolumbamine was monitored by direct detection of the latter using UPLC-MS/MS. The UPLC 
method was carried out as described previously9; detection was carried out using a Thermo TSQ 
Endura triple quadrupole mass spectrometer in ESI positive mode using selected reaction monitoring 
(SRM). Samples were prepared by drying the aliquots using a SpeedVac centrifugal evaporator 
(Genevac) and resuspending them in 100 ʅ>  ? ? % acetic acid, and they were analysed alongside 
authentic standards of known concentration. Scoulerine was detected at 1.85-2.55 min post injection 
by CID of the parental ion of 328.049 m/z, and tetrahydrocolumbamine at 2.55-3.25 min by CID of the 
parental ion of 342.080 m/z, and monitoring the product ions with 178 m/z. Data were processed 
using Thermo Xcalibur (Thermo Fisher Scientific) and GRAFIT (Erithacus Software, East Grinstead UK). 
 
Crystallisation and Data Collection 
All PSMT1 variants were crystallised using the sitting drop method at 20 ࣙC with a 1:1 ratio of protein 
to crystallisation well solution. An initial W^Dd ?td ‘ĂƉŽ ?ĐƌǇƐƚĂů was grown with 15 mg mL-1 protein 
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over a well comprised of 0.9 M sodium succinate, 0.1 M HEPES pH 7.0, 0.1 M sodium citrate, 1 % (w/v) 
polyethylene glycol (PEG) 2000. Co-crystallisation experiments with 12 mg mL-1 PSMT1 and 4.7 mM 
SAM produced crystalsover 0.1 M HEPES pH 7.0, 1 M sodium succinate, 1 % PEG 2000. PSMT1 SER 
variants were co-crystallised with 15 mg mL-1 protein, with either 1 mM SAM, 0.7 mM SAH, 2 mM 
scoulerine or 2 mM tetrahydrocolumbamine, over 0.2 M di-Ammonium citrate pH 4.4-5.0, 20-25 % 
PEG 3350. Crystals were harvested into nylon-fibre mounted CryoLoops ? ?,ĂŵƉƚŽŶZĞƐĞĂƌĐŚ ?ĂŶĚ
flash frozen in liquid nitrogen. All data were collected at the Diamond Light Source (Harwell) using a 
single crystal and auto-processed on the beamline with XIA233. The first structure was solved by 
molecular replacement with the program Phaser34 using PDB entry 1KYZ as model (residues 32-344), 
and improving the phases with Parrot35, followed by model building with BUCCANEER. PSMT1 WT 
crystals, in the open conformation, were sufficiently isomorphous with the initial PSMT1 WT structure 
for it to be used as a starting model for refinement with REFMAC 36. PSMT1 SER co-crystallised with 
SAH and scoulerine was solved using the SAM domain of PSMT1 WT chain A as the initial search model 
with MOLREP37. BUCCANEER38 was used in seed chain growing mode to auto-build the remaining 
residues, followed by manual model building with COOT 39 and refinement with REFMAC. Ligand 
structures were built into the 2Fo-Fc and Fo-Fc electron density maps after the refinement of protein 
residues. The PSMT1 SER D297A structures were sufficiently isomorphous with the structure of  
PSMT1 SER co-crystallised with SAM and scoulerine to use the latter with the ligands and waters 
removed as a starting model for refinement with REFMAC. Manual model building of protein residues 
with COOT and refinement with REFMAC were carried out, followed by building the ligand molecules 
into the 2Fo-Fc electron density map. 
 
 
Phylogenetic analysis of the characterised plant O-methyltransferases (OMTs) related to PSMT1 
PSMT1 (AFB74611.1) protein sequence was used as query sequence in a BLASTP search in the curated 
Swissprot database via the NCBI webpage (http://www.ncbi.nlm.nih.gov/). Protein sequences 
showing an E value <= 1E -50 and a reported function were downloaded along with all homologous 
sequences from the opium poppy as well as a structurally determined (S)-Norcoclaurine 6-O-
methyltransferase (5ICC) from Thalictrum flavum. These are: Humulus lupulus (Hlu) Xanthohumol 4-
OMT (B0ZB56.1), Hlu Desmethylxanthohumol 6'-OMT (B0ZB55.1), Papaver somniferum (Pso) (R,S)-
Reticuline 7-OMT (Q6WUC2.1), Coptis japonica (Cja) 3'-Hydroxy-N-methyl-(S)-coclaurine 4'-OMT 
(Q9LEL5.1), Pso 3'-Hydroxy-N-methyl-(S)-coclaurine 4'-OMT1 (Q7XB11.1), Pso 3'-Hydroxy-N-methyl-
(S)-coclaurine 4'-OMT2 (Q7XB10.1), Thalictrum flavum (Tfl) (S)-Norcoclaurine 6-OMT (5ICC), Cja (R,S)-
Norcoclaurine 6-OMT (Q9LEL6.1), Pso Norreticuline 7-OMT (C7SDN9.1), Pso (R,S)-Norcoclaurine 6-
OMT (Q6WUC1.1), Pso PSMT3 (AFB74613.1), Cja Columbamine OMT (Q8H9A8.1), Pso PSMT2 
(AFB74612.1), Sorghum bicolor (Sbi) 5-Pentadecatrienyl resorcinol OMT (A8QW53.1), Pisum sativum 
(Psa) Isoflavone 4'-OMT (O24305.1), Glycyrrhiza echinate (Gec) Isoflavone 7-OMT (Q84KK5.1), 
Medicago sativa (Msa) Isoflavone 7-OMT 8 (O24529.1), Catharanthus roseus (Cro) Myricetin OMT 
(Q8GSN1.1), Cro Tabersonine 16-OMT (B0EXJ8.1), Vitis vinifera (Vvi) Trans-resveratrol di-OMT 
(B6VJS4.2), Ocimum basilicum (Oba) Eugenol OMT (Q93WU2.1), Oba Chavicol OMT (Q93WU3.1), Ruta 
graveolens (Rgr) Anthranilate NMT (A9X7L0.1), Pimpinella anisum (Pan) Trans-anol OMT1 (B8RCD3.1), 
Oryza sativa (Osa) Naringenin 7-OMT (Q0IP69.2), Sbi Eugenol OMT (A8QW52.1), Arabidopsis thaliana 
(Ath) Indole glucosinolate OMT1 (Q9LPU5.1), Mesembryanthemum crystallinum (Mcr) Inositol 4-OMT 
(P45986.1), Msa Chalcone OMT (P93324.1), Clarkia breweri (Cbr) (Iso)eugenol OMT (O04385.2), Ath 
Flavone 3'-OMT (Q9FK25.1), Chrysosplenium americanum (Cam) Quercetin 3-OMT (P59049.1), Msa 
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Caffeic acid 3-OMT (P28002.1), Cja (S)-Scoulerine 9-OMT (Q39522.1), Pso PSMT1 (AFB74611.1), Pso 
predicted OMT (AKO60157.1). 
Protein sequence alignments were made with ClustalX. Only conserved residue blocks in the 
alignment regions were used in the subsequent phylogenetic analyses. The best-scoring maximum 
likelihood tree of a thorough maximum likelihood analysis in conjunction with bootstrap analyses of 
100 replicates was carried out with RAxML and the tree was rooted using mid-point rooting method. 
Groups with above 70% bootstrap value were considered as strongly supported (Figure S3).  
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Table S1. X-ray data and structure refinement statistics 
 
Protein WT WT SER SER SER D297A SER D297A 
Ligand  ?ĂƉŽ ? SAM 
SCU and 
SAH 
SCU and 
SAM 
SCU and 
SAH 
SCU and 
SAM 
Space group P 32 2 1 P 32 2 1 P 21 P 21 P 21 P 21 
Cell 
dimensions  
a, b, c (Å) 
112.0, 
112.0, 304.8 
111.1, 
111.1, 302.4 
68.0, 75.9, 
76.2 
68.2, 75.9, 
76.6 
68.9, 76.6, 
77.2 
68.2, 75.9, 
76.6 
D ?ɴ ?ɶ ? ? ?
90.0, 90.0, 
120.0 
90.0, 90.0 
120.0 
90.0, 101.7, 
90.0 
90.0, 101.6, 
90.0 
90.0, 101.6, 
90.0 
90.0, 101.5, 
90.0 
Resolution (Å) 97.00 (3.05) 101.00(3.00) 74.72(1.49) 75.11(1.29) 75.71(1.20) 53.31(1.50) 
Rmerge 0.151(1.607) 0.099(1.873) 0.075(0.837) 0.052(0.813) 0.069(0.694) 0.065(0.128) 
Rpim 0.052(0.561) 0.034(0.652) 0.046(0.541) 0.037(0.604) 0.046(0.580) 0.054(0.104) 
/ ?ʍ/ 10.7 (1.6) 16.3 (1.3) 9.3 (1.4) 9.5 (1.7) 7.2 (1.2) 12.2 (7.8) 
Completeness 
(%) 100.0(100.0) 100.0(100.0) 99.7(99.1) 95.5(92.3) 97.3(88.7) 97.6(96.0) 
CC(1/2) 0.997(0.592) 0.999(0.530) 0.997(0.569) 0.997(0.511) 0.995(0.532) 0.993(0.982) 
Redundancy 9.9 (10.0) 10.0 (10.1) 4.2 (4.1) 3.6 (3.6) 3.1 (2.0) 4.3 (4.4) 
Refinement 
No. reflections 41153 42222 117152 183080 225776 113281 
Rwork / Rfree 0.21/0.26 0.20/0.27 0.13/0.18 0.12/0.16 0.12/0.13 0.10/0.14 
No. atoms 
Protein 10068 10150 5463 5556 5740 5566 
Ligand/ion 0 108 100 102 100 100 
Water 0 0 573 597 894 768 
B-factors (Å2) 
Protein 65.4 86.9 19.0 18.0 15.3 14.5 
Ligand/ion n/a 71.2 12.6 12.5 9.8 9.1 
Water n/a n/a 29.3 30.4 31.2 30.5 
R.m.s. 
deviations 
Bond lengths 
(Å) 0.007 0.009 0.015 0.016 0.014 0.016 
Bond angles (°) 1.597 1.716 1.852 1.962 1.942 1.904 
Ramachandran 
plot residues       
In favoured 
regions (%) 91.0 90.2 97.2 97.7 97.7 98.3 
In allowed 
regions (%) 7.2 6.7 2.8 2.3 2.3 1.7 
In 
 ?ĚŝƐallowed ? 
regions (%) 1.8 3.1 0 0 0 0 
PDB codes 
 6I5Q 6I5Z 6I6K 6I6L 6I6M 6I6N 
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Table S2. Oligonucleotide primers used for surface entropy reduction mutants and sequencing 
 
SER Mutations 
Lys114Ala A340G A341C 
Forward 5'-gttctattctttctgtttctactacagcaaaatcaatcaacagaggaggagatg-3' 
Reverse 5'-catctcctcctctgttgattgattttgctgtagtagaaacagaaagaatagaac-3' 
Lys115Ala A343G A344C 
Forward 5'-ttctttctgtttctactacagcagcatcaatcaacagaggaggagatg-3' 
Reverse 5'-catctcctcctctgttgattgatgctgctgtagtagaaacagaaagaa-3' 
Active Site Mutants 
Asp287Ala A890C, T891C 
Forward 5'-aaaatgggtactgcacgcttggggtgatgaacgat-3'  
Reverse 5'-atcgttcatcaccccaagcgtgcagtacccatttt-3' 
 
His296Ala C886G, A887C 
Forward 5'-gttgctaaaatgggtactggccgattggggtgatgaacga-3' 
Reverse 5'-tcgttcatcaccccaatcggccagtacccattttagcaac-3'  
 
His296Phe C886T A887T 
Forward 5'-gttgctaaaatgggtactgttcgattggggtgatgaacga-3' 
Reverse 5'-tcgttcatcaccccaatcgaacagtacccattttagcaac-3' 
 
His296Asn C166A 
Forward 5'-ttgctaaaatgggtactgaacgattggggtgatgaac-3' 
Reverse 5'-gttcatcaccccaatcgttcagtacccattttagcaa-3' 
 
Thr39Ala A835G, G837A 
Forward 5'-caatggtgtctgttatctttcagaagcagctaacttggggaagttaata-3' 
Reverse 5'-tattaacttccccaagttagctgcttctgaaagataacagacaccattg-3' 
Sequencing Primers 
SeqPrimer 1 ¶-TCGGAACTGACGCAAAAGT-¶ 
SeqPrimer 2 5'-GTGAGCGGATAACAATTCC-3' 
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Figure S1. Current proposed biosynthetic pathway to noscapine 1-3. Noscapine is shown in a shaded 
box and the PSMT1 catalysed reaction in red.  
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Figure S2. Conserved ligand binding features. 
A. A summary of conserved features involved in SAM binding based on chalcone4 isoflavone-4 caffeic 
acid- 5 and norcoclaurine 6-6 O-ŵĞƚŚǇůƚƌĂŶƐĨĞƌĂƐĞƐ ?  ? dŚĞ ĐŽŶƐĞƌǀĞĚ WŚĞ  ?ŵĞƚŚŝŽŶŝŶĞ “ŵŽƚŝĨ ?4 
involved in recognition of the acceptor phenolic group 
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Figure S3. Phylogenetic analysis of characterized plant O-Methyltransferases. 
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Figure S4. Proposed key features related to substrate binding of functionally characterised plant 
OMTs and relevant substrate chemical structures. Enzyme order follows the phylogenetic tree 
arrangement in Fig S3. The four structures shown in Figure  4 are shaded in yellow rows.  
This Excel spreadsheet has been uploaded as a separate file.  
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Q9LEL5.1        115ILGMTQKDFMTPWHS....-LSSTRLILDIDMLVNTG-GKERTKEVWEKIVKSAGFSG333 
Q7XB11.1        118ILGLSQKDFLFVWNF....-LTKARLILDIDMLVNTG-GRERTAEDWENLLKRAGFRS337 
Q7XB10.1        121ILGMTQKDFMVSWHF....-LTKTRLILDIDMLVNTG-GRERTADDWENLLKRAGFRS340 
5ICC            111ILTITDKDFMAPWHY....-YTKMRLTLDLDMMLNTG-GKERTEEEWKKLIHDAGYKG332 
Q9LEL6.1        110ILAITDKDFMAPWHY....-YTKMRLTLDLDMMLNTG-GKERTEEEWKKLIHDAGYKG329 
C7SDN9.1        120VLGIIDEDMFAPWHI....-YSKLRLTSDIDMMVNNG-GKERTEKEWEKLFDAAGFAS338 
Q6WUC1.1        110ILCINDKDFLAPWHH....-YAKIRLTLDLDMMLNTG-GKERTKEEWKTLFDAAGFAS328 
AFB74613.1      109ILSVTDKDFTAPWNH....-YSKSRLAMDLAMMLHTG-GKERTEEDWKKLIDAAGFAS321 
Q8H9A8.1        116VMLQTHPEEFSVWSH....-FTSARLSMGMDMMLMSG--KERTKKEWEDLLRKANFTS334 
AFB74612.1      118VLAISCEMMVVVWHE....-LTQAKLSLDLTVMNHGG-GRERTKEDWRNLIEMSGFSR339 
A8QW53.1        127LNHVLSPFRDSPLSM....KLLETQVIYDLHLMKIG--GVERDEQEWKKIFLEAGFKD357 
O24305.1        121VKGALHPSSLDMWGV....GLTELQLEYDVVMLTMFL-GKERTKKEWEKLIYDAGFSR343 
Q84KK5.1        120VECVLDPTLSGSYHQ....EITGTKLLMDVNMACLN--GKERSEEEWKKLFIEAGFRD340 
O24529.1        115VECVLDPTLSGSYHE....QVTQIKLLMDVNMACLN--GKERNEEEWKKLFIEAGFQH335 
Q8GSN1.1        108VLGVNQIAELKAWNA....EAVKAQISSDIDMMVFFT-AKERTEEEWATLFREAGFSG331 
B0EXJ8.1        115VLTMADPVQLKAWES....HLVKTQTSMDMAMLVNFA-AKERCEKEWAFLFKEAGFSD337 
B6VJS4.2        118VLAMLDPILTKPWHY....KSTETQLFFDMTMMIFAP-GRERDENEWEKLFLDAGFSH340 
Q93WU2.1        120VQVVLDPTFTNPWHH....EVLEDQLHFDMAMMCYFN-AKERTMSEWEKLIYDAGFKS240 
Q93WU3.1        119VQVVLDPTFTNPWHY....EVLEDQLHFDMAMMSYFN-AKERTMNEWEKLISAAGFTS330 
 
B0ZB56.1        122VAFMTHPYLSAPWSC....-FDDAAVMLDIALMA-LTRGKERTEKEWKRVLEEGGFPR342 
B0ZB55.1        114VLMQTHPLSMAVWHF....-FDETRMVYDLLIPX-FSGGKERTELEWKRLLNEAGFTS334 
Q6WUC2.1        116VLWETNPILLKPWQY....-FDKMGLIFDVLMMAHTTAGKERTEAEWKILLNNAGFPR337 
 
A9X7L0.1        129MALPLDKVFMESWMG....SSARETSLLDVLLMTRDGGGRERTQKEFTELAIGAGFKG347 
B8RCD3.1        120LKLIHHKQMQNSWEK....IIAKNISEMDIRMLLYTPGGKERTVNEFLMLGKQAGFPS339 
Q0IP69.2        134GLLNLDKVFMENWYY....AAQEAFRLDV-MMLNRLAGGKERTQQEFTDLAVDAGFSG357 
A8QW52.1        139GFWMTSTTNMETWHN....ASQLAFDFDLGMMLFFGASGKERTEKELLELAREAGFSG358 
Q9LPU5.1        138VIVNFDSVFLNTWAQ....INANIAFDMDMLMFTQCSGGKERSRAEFEALAAASGFTH356 
P45986.1        129LVLHHDKVMMESWFH....LESHMVFSLDCHTLVHNQGGKERSKEDFEALASKTGFST347 
P93324.1        136TTFLCYPALLQVWMN....EESKLVSTLDNLMFIT-VGGRERTEKQYEKLSKLSGFSK354 
O04385.2        131LLTATDKVLLEPWFY....IATKVVIHTDALMLAYNPGGKERTEKEFQALAMASGFRG349 
Q9FK25.1        126CLMNQDKVLMESWYH....LSTKQVVHVDCIMLAHNPGGKERTEKEFEALAKASGFKG344 
P59049.1        104CLMNQDKVLMESWYH....LATKGVVHIDVITVAHNPGGKERTEKEFEALAKAAGFQG322 
P28002.1        128NLMNQDKVLMESWYH....LATKGVVHIDVIMLAHNPGGKERTQKEFEDLAKGAGFQG346 
Q39522.1        142LLFTSDKAVVESFYN....AESFNALTPDLLMMALNPGGKERTTIEFDGLAKAAGFAE361 
AFB74611.1      154LLFTSDKVVVDSFFK....AESFNALIPDLLLMALNPGGKERTISEYDDLGKAAGFIK373 
AKO60157.1      147LMFVADKIVVESFYN....PESYNALTPDLLMMALNPGGKERTLLEFYDLANAAGFAK367 
 
 
 
Figure S5. Sequence alignment of characterised plant O-methyltransferases (OMTs) 
WŽƚĞŶƚŝĂů  “ŐĂƚĞŬĞĞƉĞƌ ? ƌĞƐŝĚƵĞƐ ? ĞƋƵŝǀĂůĞŶƚ ƚŽ WŚĞ ? ? ? ĂŶĚ >ĞƵ ? ? ? ? ŽĨ W^Dd ?  ?& ? ? ? ? ? ? ? ? ĂƌĞ
coloured in red and blue, respectively. Enzymes shown: Humulus lupulus (Hlu) Xanthohumol 4-OMT 
(B0ZB56.1), Hlu Desmethylxanthohumol 6'-OMT (B0ZB55.1), Papaver somniferum (Pso) (R,S)-
Reticuline 7-OMT (Q6WUC2.1), Coptis japonica (Cja) 3'-Hydroxy-N-methyl-(S)-coclaurine 4'-OMT 
(Q9LEL5.1), Pso 3'-Hydroxy-N-methyl-(S)-coclaurine 4'-OMT1 (Q7XB11.1), Pso 3'-Hydroxy-N-methyl-
(S)-coclaurine 4'-OMT2 (Q7XB10.1), Thalictrum flavum (Tfl) (S)-Norcoclaurine 6-OMT (5ICC), Cja (R,S)-
  30 
Norcoclaurine 6-OMT (Q9LEL6.1), Pso Norreticuline 7-OMT (C7SDN9.1), Pso (R,S)-Norcoclaurine 6-
OMT (Q6WUC1.1), Pso PSMT3 (AFB74613.1), Cja Columbamine OMT (Q8H9A8.1), Pso PSMT2 
(AFB74612.1), Sorghum bicolor (Sbi) 5-Pentadecatrienyl resorcinol OMT (A8QW53.1), Pisum sativum 
(Psa) Isoflavone 4'-OMT (O24305.1), Glycyrrhiza echinate (Gec) Isoflavone 7-OMT (Q84KK5.1), 
Medicago sativa (Msa) Isoflavone 7-OMT 8 (O24529.1), Catharanthus roseus (Cro) Myricetin OMT 
(Q8GSN1.1), Cro Tabersonine 16-OMT (B0EXJ8.1), Vitis vinifera (Vvi) Trans-resveratrol di-OMT 
(B6VJS4.2), Ocimum basilicum (Oba) Eugenol OMT (Q93WU2.1), Oba Chavicol OMT (Q93WU3.1), Ruta 
graveolens (Rgr) Anthranilate NMT (A9X7L0.1), Pimpinella anisum (Pan) Trans-anol OMT1 (B8RCD3.1), 
Oryza sativa (Osa) Naringenin 7-OMT (Q0IP69.2), Sbi Eugenol OMT (A8QW52.1), Arabidopsis thaliana 
(Ath) Indole glucosinolate OMT1 (Q9LPU5.1), Mesembryanthemum crystallinum (Mcr) Inositol 4-OMT 
(P45986.1), Msa Chalcone OMT (P93324.1), Clarkia breweri (Cbr) (Iso)eugenol OMT (O04385.2), Ath 
Flavone 3'-OMT (Q9FK25.1), Chrysosplenium americanum (Cam) Quercetin 3-OMT (P59049.1), Msa 
Caffeic acid 3-OMT (P28002.1), Cja (S)-Scoulerine 9-OMT (Q39522.1), Pso PSMT1 (AFB74611.1), Pso 
predicted OMT (AKO60157.1). 
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